KYTX
Price
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$161.31M | -$127.48M | -$60.37M | -$28.89M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$161.31M | -$127.48M | -$60.37M | -$28.89M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.68 | -0.63 | +7.3% |
| Dec 2025 | -0.86 | -0.80 | +6.8% |
| Sep 2025 | -0.97 | -0.85 | +12.5% |
| Jun 2025 | -1.04 | -0.97 | +7.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.68 | 5 | $0 | 0.0% |
| Next quarter | -0.69 | 5 | $0 | 0.0% |
| Current year | -2.77 | 5 | $0 | 0.0% |
| Next year | -3.07 | 5 | $15.16M | 0.0% |
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 27, 26 | CLARK IAN THORNTON Director |
STOCK | 5.09K | $0 | Direct |
| May 27, 26 | COHEN FREDERICK E. M.D. PH.D. Director |
STOCK | 5.09K | $0 | Direct |
| May 27, 26 | SEIDENBERG BETH C Director |
STOCK | 5.09K | $0 | Direct |
| May 27, 26 | AKTAR MERT Director |
STOCK | 5.09K | $0 | Direct |
| Mar 13, 26 | GRASSO MARC Chief Financial Officer |
STOCK | 10.00K | $0 | Direct |
| Mar 13, 26 | BIDDLE WARNER WESTON Chief Executive Officer |
STOCK | 58.00K | $0 | Direct |
| Mar 13, 26 | GEHCHAN NAJI M.D. Officer |
STOCK | 18.00K | $0 | Direct |
| Feb 24, 26 | MILLER ANDREW CRAIG Director |
STOCK | 11.01K | $0 | Direct |
| Feb 24, 26 | EMANY SRAVAN KUMAR Director |
STOCK | 11.01K | $0 | Direct |
| Jan 12, 26 | SHAW CHRISTI L Officer and Director |
STOCK | 54.30K | $0 | Direct |
| Dec 18, 25 | SEIDENBERG BETH C Director |
BUY | 133.33K | $1000.00K | Indirect |
| Dec 18, 25 | WESTLAKE BIOPARTNERS FUND I, L.P. Beneficial Owner of more than 10% of a Class of Security |
BUY | 133.33K | $1000.00K | Indirect |
| Dec 15, 25 | WALKER KAREN MARIE Chief Technology Officer |
SELL | 24.00K | $292.78K | Direct |
| Dec 15, 25 | WALKER KAREN MARIE Chief Technology Officer |
CONVERSION | 24.00K | $115.91K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AKTAR MERT |
Director | 21.73K | Stock Award(Grant) |
BIDDLE WARNER WESTON |
Chief Executive Officer | 58.00K | Stock Award(Grant) |
CLARK IAN THORNTON |
Director | 21.73K | Stock Award(Grant) |
COHEN FREDERICK E. M.D. PH.D. |
Director | 4.55M | Stock Award(Grant) |
GEHCHAN NAJI M.D. |
Officer | 18.00K | Stock Award(Grant) |
SEIDENBERG BETH C |
Director | 4.68M | Stock Award(Grant) |
SHAW CHRISTI L |
Officer and Director | 70.94K | Stock Award(Grant) |
SPIEGELMAN DANIEL KEITH |
Director | 16.63K | Stock Award(Grant) |
WALKER KAREN MARIE |
Chief Technology Officer | 22.64K | Sale |
WESTLAKE BIOPARTNERS FUND I, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
Moving averages & technicals
Risk profile
Unusual options activity
| Side | Strike | Expiry | Volume | Open int. | Vol / OI | Notional | IV | Score | |
|---|---|---|---|---|---|---|---|---|---|
| PUT | 7.50 | Mar 19, 27 208d |
220 | 218 | 1.0× | $58.30K | 127% | mid | 38 |
How this is calculated, and what it cannot see
A contract is flagged when today's volume approaches or exceeds its open interest, the position is worth at least $40,000, and at least 150 contracts changed hands. Open interest is what was outstanding at yesterday's close, so volume above it means the flow cannot all be closing — something is being opened.
The score weights four things: volume against open interest, dollar notional, volume against the rest of that chain, and where the last print sat inside the bid/ask spread.
What it cannot see. Volume here is a daily total, so ten small orders and one large one are indistinguishable — this is not block or sweep detection, which needs exchange-level time and sales. The print column compares the last trade to the current quote, which is a proxy for who was the aggressor, not a tagged flag. Quotes are delayed. A single large trade can be a hedge, a roll, or one leg of a spread, and none of those mean what a naked directional bet would mean.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.